Summary: Inverse interviews Dr. Mathew Hoskins about his experience participating in MAPS’ ongoing Phase 1 study of MDMA-assisted psychotherapy for therapists in training to conduct clinical trials of MDMA-assisted psychotherapy for PTSD. “We urgently need new treatments,” explains Hoskins. “MDMA is probably the most promising thing that I’ve heard of.”